Extracellular Lactate Inhibits HIV Infection in Dendritic Cells by Downregulating CD4 Expression

Cellular metabolism and cellular microenvironments influences immune-cell function. We previously demonstrated that interleukin-27 (IL-27)-induced monocyte-derived dendritic cells (27DCs) exhibit resistance to HIV-1. A mechanistic study for this antiviral effect suggested that in addition to inducing antiviral genes, IL-27 may influence cellular metabolism that contributes to the anti-HIV effect. During course of study, we observed that 27DCs accumulated lactate in culture supernatants by 5.7-fold increase compared with cultures of untreated DCs (iDCs) (12.1±1.3 versus 2.1±0.2 mM). Here, we assesses extracellular role of lactate on HIV infection. Healthy donors CD14+ monocytes were differentiated to DCs using GM-CSF and IL-4 in the absence of presence of lactate (Lac). DCs were infected with HIVAD8. Lactate-induced DC (LacDC) reduced R5-tropic HIV-1 AD8 replication by 71.1±8.3% without detectable cytotoxicity compared to that in untreated cells (iDCs). LacDCs exhibited reductions in viral particles binding, membrane fusion of viral particles, and HIV reverse-transcription by 78.5±2.8% (n=3, p<0.05), 78.7±3.3% (n=3, p<0.01), 86.2±5.7% (n=3. p<0.01), respectively. FACS analyses demonstrated that surface CD4 expression on LacDC decreased by 56.6±5.1% (n=5 , p<0.05) compared to iDC, whereas total cellular CD4 protein amount and surface CCR5 expression were not significantly altered. Neither the lactate transporter inhibitor nor the lactate receptor restored HIV-1 susceptibility. These findings demonstrate that lactate exposure during dendritic-cell differentiation induces an HIV-1-resistant phenotype associated with reduced surface CD4 availability and impaired viral attachment. This study identifies extracellular lactate as a modulator of dendritic-cell susceptibility to HIV-1 and suggests a potential link between IL-27-associated metabolic changes and antiviral immunity.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.766458
Primary Topic
HIV Research and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Extracellular Lactate Inhibits HIV Infection in Dendritic Cells by Downregulating CD4 Expression

Sylvain Laverdure, Bharatwaj Sowrirajan, Tomozumi Imamichi, Mayra Marquez et al.
bioRxiv (Cold Spring Harbor Laboratory)
HIV Research and Treatment
preprint

Extracellular Lactate Inhibits HIV Infection in Dendritic Cells by Downregulating CD4 Expression

Sylvain Laverdure, Bharatwaj Sowrirajan, Tomozumi Imamichi, Mayra Marquez, Qian Chen, Adam Rupert, Jordan Metz, Jun Yang, Whitney Bruchey, Udeshika Kariyawasam
preprint en

Abstract

Cellular metabolism and cellular microenvironments influences immune-cell function. We previously demonstrated that interleukin-27 (IL-27)-induced monocyte-derived dendritic cells (27DCs) exhibit resistance to HIV-1. A mechanistic study for this antiviral effect suggested that in addition to inducing antiviral genes, IL-27 may influence cellular metabolism that contributes to the anti-HIV effect. During course of study, we observed that 27DCs accumulated lactate in culture supernatants by 5.7-fold increase compared with cultures of untreated DCs (iDCs) (12.1±1.3 versus 2.1±0.2 mM). Here, we assesses extracellular role of lactate on HIV infection. Healthy donors CD14+ monocytes were differentiated to DCs using GM-CSF and IL-4 in the absence of presence of lactate (Lac). DCs were infected with HIVAD8. Lactate-induced DC (LacDC) reduced R5-tropic HIV-1 AD8 replication by 71.1±8.3% without detectable cytotoxicity compared to that in untreated cells (iDCs). LacDCs exhibited reductions in viral particles binding, membrane fusion of viral particles, and HIV reverse-transcription by 78.5±2.8% (n=3, p<0.05), 78.7±3.3% (n=3, p<0.01), 86.2±5.7% (n=3. p<0.01), respectively. FACS analyses demonstrated that surface CD4 expression on LacDC decreased by 56.6±5.1% (n=5 , p<0.05) compared to iDC, whereas total cellular CD4 protein amount and surface CCR5 expression were not significantly altered. Neither the lactate transporter inhibitor nor the lactate receptor restored HIV-1 susceptibility. These findings demonstrate that lactate exposure during dendritic-cell differentiation induces an HIV-1-resistant phenotype associated with reduced surface CD4 availability and impaired viral attachment. This study identifies extracellular lactate as a modulator of dendritic-cell susceptibility to HIV-1 and suggests a potential link between IL-27-associated metabolic changes and antiviral immunity.

bioRxiv (Cold Spring Harbor Laboratory)
Frederick National Laboratory for Cancer Research (US)
U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon